Salmoporc is the first and only live attenuated sow and piglet vaccine against Salmonella Typhimurium (STM).
Salmoporc is now available in the majority of the European countries. Geo extension is planned in all swine producing countries worldwide.
In the European Union (EU), human salmonellosis is the second most reported zoonosis (after human campylobacteriosis), and Salmonella is the most frequently reported causative agent isolated in foodborne outbreaks (EFSA, 2016, 2017, 2018). In pigs and pig meat, STM and its monophasic variants, are the most reported Salmonella serotypes (EFSA, 2016, 2017, 2018)
Salmoporc gives completely protection against S.Typhimurium and ist monophasic variants.
Moreover, internal data demonstrate cross protection also against S.dDerby.
The reduction in antibiotic use and the emerging of pig production without antibiotics is increasing and offer a huge opportunity for Salmoporc